Holen Sie sich die Stockscreener-App
1.44
2.04%
-0.03
Handel nachbörslich:
1.50
0.06
+4.17%
Inmune Bio Inc Aktie (INMB) Neueste Nachrichten
Is INmune Bio Inc. stock a buy for dividend growthPortfolio Return Summary & Weekly Top Performers Watchlists - mfd.ru
INmune Bio Advances CORDStrom Toward Rare Disease Commercialization - TipRanks
Inmune Bio Inc Advances CORDStrom and XPro1595 Regulatory Pathways - TradingView
Inmune Bio plans to seek approval of RDEB treatment in UK, US, and EU in 2026 - Epidermolysis Bullosa News
Inmune Bio announces FDA alignment on integrated Phase 2B/3 registration pathway for Xpro1595 in early Alzheimer's disease - marketscreener.com
INMB Stock Gained 3% Today – What Did The FDA Say About Its Alzheimer’s Trial? - Stocktwits
INMB Stock Rises Pre-Market – What Did The FDA Say About Its Alzheimer’s Trial? - Asianet Newsable
INmune Bio Gains FDA Alignment On Phase 2b/3 Trial Design For Alzheimer's Drug XPro1595 - Nasdaq
INmune Bio Announces FDA Alignment on Integrated Phase 2b/3 Registration Pathway for XPro1595 in Early Alzheimer’s Disease - The Manila Times
FDA sets path for 1,000-patient early Alzheimer’s trial using immune therapy - Stock Titan
Will INmune Bio Inc. benefit from geopolitical trends2025 Market Outlook & Daily Growth Stock Investment Tips - mfd.ru
Is INmune Bio Inc. stock a value trapRate Hike & Safe Entry Momentum Tips - mfd.ru
INmune Bio submits pre-submission package for CORDStrom with MHRA - Yahoo Finance
INmune Bio, Inc. (NASDAQ:INMB) Given Average Rating of “Reduce” by Brokerages - Defense World
Inmune Bio Inc Submitted Pre-Submission Package For Cordstrom With Uk's Mhra - TradingView
Inmune Bio Advances Cordstrom™ Towards Uk Marketing Authorization In Rdeb - TradingView
INmune Bio (INMB) Advances with Regulatory Submission for CORDSt - GuruFocus
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB - The Manila Times
Rare 'butterfly skin' disease therapy takes key step toward UK review - Stock Titan
Death Cross: Whats the profit margin of INmune Bio IncJuly 2025 Gainers & Verified Chart Pattern Signals - baoquankhu1.vn
Smart Money: Will INmune Bio Inc benefit from geopolitical trendsJuly 2025 Trends & Consistent Profit Trading Strategies - baoquankhu1.vn
Retail Surge: What is the earnings history of INmune Bio Inc2025 Valuation Update & Fast Gaining Stock Reports - baoquankhu1.vn
Aug Movers: Will INmune Bio Inc benefit from geopolitical trendsInsider Buying & Expert Approved Momentum Ideas - baoquankhu1.vn
INmune Bio: Undervalued Pipeline with 2026 Clinical and Regulatory Catalysts Driving Buy Rating - TipRanks
INmune Bio outlines 2025 progress on Alzheimer’s and RDEB therapies By Investing.com - Investing.com Australia
New Highs: Can ProShares Trust ProShares UltraShort SmallCap600 expand into new marketsDollar Strength & Reliable Intraday Trade Plans - baoquankhu1.vn
INmune Bio outlines 2026 regulatory path in shareholder letter - TipRanks
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives - TradingView
INmune Bio (INMB) Reflects on Key Progress and Financial Stabili - GuruFocus
INmune Bio (INMB) Reflects on Key Progress and Financial Stability in 2025 - GuruFocus
INmune Bio outlines 2025 progress on Alzheimer’s and RDEB therapies - Investing.com
INmune Bio, Inc. Provides Investor Update on 2025 Progress and Future Regulatory Plans - Quiver Quantitative
ETF Watch: How liquid is Capital Growth Mortgage Investors L P Preferred Security stockJuly 2025 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn
Sell Signal: Will Reading International Inc benefit from geopolitical trends2025 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug Rallies: What is the earnings history of INmune Bio IncMarket Performance Report & Daily Technical Forecast Reports - baoquankhu1.vn
Is INmune Bio Inc. trading at a discountDay Trade & Reliable Price Breakout Alerts - bollywoodhelpline.com
Take Profit: Is Varex Imaging Corporation still a buy after recent gains - baoquankhu1.vn
INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial - MSN
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Aug Breakouts: How liquid is INmune Bio Inc. stockJuly 2025 Momentum & Consistent Return Strategy Ideas - baoquankhu1.vn
How INmune Bio Inc stock reacts to bond yieldsQuarterly Market Review & Weekly High Return Opportunities - Bộ Nội Vụ
How interest rate cuts could boost INmune Bio Inc. stockTrail vs Road Selection & lightweight options for faster days - Улправда
Can INmune Bio Inc. stock deliver sustainable ROEBreakout Watch & High Conviction Investment Ideas - Улправда
Risk Recap: How INmune Bio Inc. stock reacts to bond yieldsJuly 2025 Trends & Risk Controlled Swing Trade Alerts - ulpravda.ru
Will INmune Bio Inc. stock outperform Dow Jones indexLayoff News & Expert-Curated Trade Recommendations - ulpravda.ru
Is INmune Bio Inc. stock a top pick in earnings seasonPortfolio Performance Report & Free Daily Entry Point Trade Alerts - ulpravda.ru
How INmune Bio Inc. stock benefits from strong dollar2025 Buyback Activity & Real-Time Buy Zone Alerts - ulpravda.ru
What hedge fund activity signals for INmune Bio Inc. stock2025 Volume Leaders & Safe Capital Growth Stock Tips - ulpravda.ru
Will INmune Bio Inc. stock benefit from automation2025 Market WrapUp & AI Based Trade Execution Alerts - ulpravda.ru
Is INmune Bio Inc. stock a good choice for value investorsTrade Risk Assessment & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
What is the fair value of INmune Bio Inc. stock nowTrade Volume Summary & AI Forecast Swing Trade Picks - ulpravda.ru
INmune Bio reverses early gains after stock offering - MSN
Energy Moves: Can INmune Bio Inc. stock deliver sustainable ROEMarket Risk Summary & Free Safe Capital Growth Stock Tips - Улправда
INmune Bio Inc.Common stock (NQ: INMB - FinancialContent
Is INmune Bio Inc. stock vulnerable to regulatory risksReal-Time Stock Alerts & Boost Wealth With Growth - Улправда
INmune Bio (INMB) price target decreased by 37.50% to 5.36 - MSN
Aug EndMonth: Will INmune Bio Inc stock outperform Dow Jones indexLong Setup & Verified Momentum Watchlists - moha.gov.vn
Can INmune Bio Inc. stock withstand economic slowdownEarnings Revision Updates & Breakout Portfolio Performance - ulpravda.ru
INMUNE BIO INC (INMB) Stock Technical Analysis - Chartmill
INmune Bio Inc Stock Analysis and ForecastTechnology Stock Trends & Exceptional Capital Growth - earlytimes.in
How INmune Bio Inc. stock performs in high volatility marketsEnergy Sector Updates & Small Investment Capital Tips - bollywoodhelpline.com
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):